Oculomex is a health technology company that utilises AI-driven retinal imaging to provide non-invasive cardiovascular risk assessments.
Oculomex has raised $320K in total funding. The most recent round was Pre-Seed. The last funding was announced in November 2025.
Oculomex's investors include SFC Capital.
Oculomex is headquartered in London, United Kingdom.
Oculomex is a health technology company that utilises AI-driven retinal imaging to provide non-invasive cardiovascular risk assessments.
Oculomex is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oculomex — Funding & Investors." VCBacked, November 26, 2025, https://www.vcbacked.co/company/oculomex. Accessed July 19, 2026.
VCBacked. (2025). Oculomex — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/oculomex
{{cite web |title=Oculomex — Funding & Investors |url=https://www.vcbacked.co/company/oculomex |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated